文献速递呼吸衰竭与机械通气心脑血管急症

急诊科以D-二聚体为核心的肺栓塞检测路径的实施、临床获益与安全性

Implementation, Clinical Benefit and Safety of a D-Dimer-Focused Pulmonary Embolism Testing Pathway in the Emergency Department.
PubMed 文献 · Ann Emerg Med · 2024-04-24
一句话结论在加拿大2个急诊科实施仅用D-二聚体(<500 ng/mL排除PE)的肺栓塞检测路径依从性达97.6%,未减少影像检查比例但提高了影像阳性率,30天内漏诊PE 0.04%。

这项前瞻性多中心实施研究在2个急诊科开展,纳入疑似肺栓塞(PE)患者,D-二聚体≥500 ng/mL时行CTPA或通气-灌注扫描,<500 ng/mL或影像阴性则排除PE。2018年1月至2021年6月共16,155例患者接受PE检测,实施后占33.4%、实施前占30.7%、外部对照点占35.9%。路径依从性97.6%(实施后vs实施前aOR 5.26,95%CI 1.70-16.26),影像检查比例无影响,影像阳性率提高(aOR 4.89,95%CI 1.17-20.53),阴性检测后30天内诊断PE 2例(0.04%,95%CI 0.01%-0.16%)。作者结论认为仅用D-二聚体的策略接受度高,D-二聚体<500 ng/mL可安全排除PE。

要点

  • 疑似PE患者仅用D-二聚体策略:D-二聚体<500 ng/mL或影像阴性即排除PE,路径依从性97.6%(实施后vs实施前aOR 5.26,95%CI 1.70-16.26)。
  • 实施该路径后接受肺影像检查的患者比例无变化,但影像阳性率提高(aOR 4.89,95%CI 1.17-20.53)。
  • 安全性:阴性PE检测后30天内诊断PE 2例(0.04%,95%CI 0.01%-0.16%)。
  • 研究期间共16,155例患者接受PE检测,实施后占33.4%、实施前占30.7%、外部对照点占35.9%。

适用人群与场景

  • 急诊科疑似肺栓塞(PE)并接受PE检测的患者。

诊断标准与关键阈值

  • D-二聚体≥500 ng/mL时行影像检查(CTPA或通气-灌注扫描)。
  • D-二聚体<500 ng/mL或影像阴性即可排除PE。

处置流程与药物剂量

  • 疑似PE患者先行D-二聚体检测;D-二聚体≥500 ng/mL时行CTPA或通气-灌注扫描;D-二聚体<500 ng/mL或影像阴性则排除PE。

研究设计与关键结果

  • 前瞻性多中心实施研究,在2个急诊科开展,设历史对照和外部对照;2018年1月至2021年6月共16,155例患者接受PE检测,实施后占33.4%、实施前占30.7%、外部对照点占35.9%。
  • 主要实施结局:路径依从性97.6%,实施后vs实施前aOR 5.26(95%CI 1.70-16.26)。
  • 主要临床获益结局:接受肺影像检查的患者比例无影响;影像阳性率提高aOR 4.89(95%CI 1.17-20.53)。
  • 主要安全结局:阴性PE检测后30天内诊断PE 2例(0.04%,95%CI 0.01%-0.16%)。

证据类型、等级与局限

  • 证据类型:前瞻性多中心实施研究,设历史对照和外部对照。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,仅用D-二聚体的PE检测策略接受度高,实施与影像阳性率提高相关,D-二聚体<500 ng/mL可安全排除PE。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Computed tomography pulmonary angiogram (CTPA) is overused during pulmonary embolism (PE) testing in the emergency department (ED), whereas prediction rules and D-dimer are underused. We report the adherence, clinical benefit, and safety of a D-dimer-only strategy to guide need for PE imaging in the ED.

METHODS: This was a prospective multicenter implementation study in 2 EDs with historical and external controls. Patients with suspected PE underwent D-dimer testing and imaging (CTPA or ventilation-perfusion scan) when D-dimer levels were 500 ng/mL or more. PE was ruled out if D-dimer was less than 500 ng/mL or with negative imaging. The primary implementation outcome was the proportion of patients tested for PE in adherence with the pathway. The primary clinical benefit outcome was the proportion of patients tested for PE who received pulmonary imaging. The primary safety outcome was diagnosis of PE in the 30 days following negative PE testing postimplementation.

RESULTS: Between January 2018 and June 2021, 16,155 patients were tested for PE, including 33.4% postimplementation, 30.7% preimplementation, and 35.9% in an external control site. Adherence with the D-dimer-only pathway was 97.6% (adjusted odds ratio (aOR) post- versus preimplementation 5.26 (95% confidence interval 1.70 to 16.26). There was no effect on the proportion undergoing PE imaging. Imaging yield increased aOR 4.89 (1.17 to 20.53). Two cases of PE (0.04%; 0.01% to 0.16%) were diagnosed within 30 days.

CONCLUSION: In this Canadian ED study, the uptake of a D-dimer-only PE testing strategy was high. Implementation was associated with higher imaging yield and a D-dimer level of less than 500 ng/mL safely excluded PE.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Germini F, Al-Haimus F, Hu Y, et al. Implementation, Clinical Benefit and Safety of a D-Dimer-Focused Pulmonary Embolism Testing Pathway in the Emergency Department. Ann Emerg Med. 2024. PMID: 38661619. doi:10.1016/j.annemergmed.2024.03.010

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。